Diabetes Care Devices - Spain | Statista Market Forecast

In Spain, the revenue in the Diabetes Care Devices market market is projected to reach US$377.60m in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 11.47%, which will lead to a market volume of US$649.90m by 2029.
When compared globally, the majority of revenue will be generated the United States, which is expected to reach US$11.71bn in 2024.
Spain is witnessing a growing demand for innovative diabetes care devices, driven by an increasing prevalence of diabetes and heightened awareness of patient-centric solutions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Spain is experiencing considerable growth, fueled by factors such as increasing prevalence of diabetes, technological advancements in monitoring devices, and heightened awareness of diabetes management among the population.

Customer preferences: Consumers in Spain are increasingly prioritizing personalized diabetes care solutions, reflecting a shift towards tailored health management. This trend is influenced by a growing awareness of the importance of lifestyle factors, such as diet and exercise, in diabetes management. Additionally, younger demographics are more inclined to embrace innovative technologies, such as continuous glucose monitors and smartphone apps, enabling real-time tracking of their health. As a result, there is a rising demand for integrated devices that combine functionality with user-friendly interfaces, aligning with the desire for proactive and informed health choices.

Trends in the market: In Spain, the Diabetes Care Devices Market is experiencing a surge in demand for advanced monitoring solutions, driven by an increasing focus on personalized diabetes management. Consumers are gravitating towards continuous glucose monitors and mobile applications that facilitate real-time health tracking. This trend highlights the significance of integrating technology into daily healthcare practices, particularly among younger populations who prioritize proactive health management. Industry stakeholders must adapt to these shifting preferences by investing in user-friendly, multifunctional devices to stay competitive in this evolving landscape.

Local special circumstances: In Spain, the Diabetes Care Devices Market is influenced by a robust healthcare system and a strong emphasis on patient education, fostering a culture of proactive health management. The country's aging population and rising obesity rates are contributing to a higher prevalence of diabetes, prompting demand for innovative care solutions. Additionally, Spain's regulatory framework encourages the adoption of advanced medical technologies, while a vibrant tech ecosystem supports the development of user-friendly devices. This combination of factors positions Spain uniquely in the global diabetes care landscape.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Spain is shaped by several macroeconomic factors including economic stability, healthcare funding, and demographic trends. A robust national economy supports increased investment in healthcare technologies, enhancing the availability of innovative diabetes management solutions. Furthermore, Spain's commitment to universal healthcare ensures that a significant portion of the population has access to necessary medical devices. The rising prevalence of diabetes, driven by an aging population and lifestyle changes, creates an urgent need for effective care solutions. Additionally, favorable fiscal policies promote research and development, further stimulating market growth in the diabetes care sector.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.